The findings of this study suggest that OUD medications are associated with decreased hospital admissions for alcohol-related acute events among persons with OUD. Although naltrexone use was more prevalent among patients with OUD with recent AUD claims, agonist treatments (buprenorphine and methadone) also were associated with fewer alcohol-related events. The present study raises key questions about the potential of OUD medications for reducing alcohol-related events and highlights the need for additional research in this area.
